• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.

作者信息

Van Allen Eliezer M, Garraway Levi A, Rosenberg Jonathan E

机构信息

Dana-Farber Cancer Institute, Boston, MA, USA.

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

出版信息

Eur Urol. 2015 Aug;68(2):e31-2. doi: 10.1016/j.eururo.2015.02.044. Epub 2015 Mar 12.

DOI:10.1016/j.eururo.2015.02.044
PMID:25770487
Abstract
摘要

相似文献

1
Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.回复：弗洛里斯·H·格罗嫩迪克、杰罗恩·德容、伊丽莎白·E·弗兰森·范德普特等。ERBB2突变特征为一组对新辅助化疗有极佳反应的肌层浸润性膀胱癌。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2015.01.014 。
Eur Urol. 2015 Aug;68(2):e31-2. doi: 10.1016/j.eururo.2015.02.044. Epub 2015 Mar 12.
2
Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.回复埃利泽·M·范·艾伦、利瓦伊·A·加拉韦和乔纳森·E·罗森伯格致编辑的信，信的内容涉及弗洛里斯·H·格罗嫩迪克、杰罗恩·德容、伊丽莎白·E·弗兰森·范·德·普特等人的文章：《ERBB2突变特征定义了一组对新辅助化疗有良好反应的肌层浸润性膀胱癌》。《欧洲泌尿外科杂志》即将发表。http://dx.doi.org/10.1016/j.eururo.2015.01.014 。
Eur Urol. 2015 Aug;68(2):e33-4. doi: 10.1016/j.eururo.2015.02.043. Epub 2015 Mar 13.
3
Re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016.
Eur Urol. 2021 Feb;79(2):e56-e57. doi: 10.1016/j.eururo.2020.11.007. Epub 2020 Nov 18.
4
Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016.
Eur Urol. 2021 Feb;79(2):e58-e59. doi: 10.1016/j.eururo.2020.11.006. Epub 2020 Nov 17.
5
Re: Siobhan P. Lynch, Yu Shen, Ashish Kamat, et al. neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.020.
Eur Urol. 2012 Sep;62(3):e65-6. doi: 10.1016/j.eururo.2012.05.061. Epub 2012 Jun 5.
6
Re: Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy: W. C. Duivenvoorden, S. Daneshmand, D. Canter, Y. Lotan, P. C. Black, H. Abdi, B. W. van Rhijn, E. E. Fransen van de Putte, P. Zareba, I. Koskinen, W. Kassouf, S. L. Traboulsi, J. E. Kukreja, P. J. Boström, B. Shayegan and J. H. Pinthus J Urol 2016;196:1627-1633.
J Urol. 2017 May;197(5):1360-1362. doi: 10.1016/j.juro.2016.12.094. Epub 2017 Feb 7.
7
Reply to Robert J. van Soest and Ronald de Wit's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.对罗伯特·J·范·索斯特和罗纳德·德·威特致编辑的信的回复，信的主题为：约翰·S·德博诺、马修·R·史密斯、弗雷德·萨德等人。醋酸阿比特龙治疗转移性去势抵抗性前列腺癌患者后的后续化疗及治疗模式：COU - AA - 302的事后分析。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2016.06.033 。
Eur Urol. 2017 Jan;71(1):e11. doi: 10.1016/j.eururo.2016.10.005. Epub 2016 Oct 14.
8
Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057.回复：史蒂文·乔尼奥、劳拉·范登伯格、伊夫琳·勒鲁特等。前列腺癌盆腔淋巴结转移的图谱。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2012.06.057 。
Eur Urol. 2013 Feb;63(2):e20. doi: 10.1016/j.eururo.2012.10.045. Epub 2012 Nov 2.
9
Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
Eur Urol. 2015 Dec;68(6):e127. doi: 10.1016/j.eururo.2015.08.019. Epub 2015 Aug 28.
10
Re: Beat Roth, Frédéric D. Birkhäuser, Pascal Zehnder, et al. Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.05.052.回复：《击败罗斯》，弗雷德里克·D·伯克豪泽、帕斯卡·策恩德等著。肠外营养不能改善根治性膀胱切除术后的恢复：一项前瞻性随机试验的结果。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2012.05.052
Eur Urol. 2012 Oct;62(4):e79; author reply e80. doi: 10.1016/j.eururo.2012.07.001. Epub 2012 Jul 13.

引用本文的文献

1
Neoadjuvant cisplatin-based chemotherapy in "primary" and "secondary" muscle-invasive bladder cancer-is it a surrogate for molecular subtypes?“原发性”和“继发性”肌层浸润性膀胱癌中基于顺铂的新辅助化疗——它是分子亚型的替代指标吗？
Transl Cancer Res. 2019 Mar;8(Suppl 2):S176-S179. doi: 10.21037/tcr.2019.01.05.